Kelly M Herremans

Kelly M Herremans, MD

University Of Florida College Of Medicine

Department: MD-SURGERY-RESIDENCY PROGRAM
Business Phone: (352) 328-2284

About Kelly M Herremans

Hometown: With my father in the Air Force, we frequently moved across the country. I graduated high school in Great Falls, MT but Gainesville has become my new hometown.

Clinical Interests: Surgical Oncology, specifically as it relates to cancer health disparities and the oral and pancreatic microbiome.

What were you looking for in a residency program? ​I really wanted a place where the residents supported one another and I knew that was the case at the University of Florida. Regardless of which residency program I chose, I knew I would be putting in long hours so it was really important to me to have a close knit support system. Gainesville also has the added bonus of affordable living and housing, which is really important during this time in life!

What are the strengths of the UF program? Hands down, the people. The residents, faculty and staff are extremely supportive and will go out of their way to help you accomplish your goals. We also have a great time together along the way. Additionally, it is particularly helpful to interact with faculty that are nationally and internationally renowned within their fields. This has helped open a number of opportunities for fellowship opportunities.

What do you like best about living in Gainesville? Definitely the weather. There really is something to be said for being able to eat lunch out on the sunny hospital terrace in the middle of January (and not having to scrape the snow off of your car!). Gainesville itself is a wonderful place to live because there are a number of fun things to do and unique places to eat. It’s also only a short drive to the beach or theme parks if you are looking for more adventure.

List of hobbies/interests: I love hanging out with my child, fur children (and my husband Patrick too). I enjoy playing golf and trying to keep my garden alive.

Teaching Profile

Courses Taught
2021
PAS5020 Intro to Medicine 2

Publications

2022
A multi-omics approach identifies pancreatic cancer cell extracellular vesicles as mediators of the unfolded protein response in normal pancreatic epithelial cells.
Journal of extracellular vesicles. 11(6) [DOI] 10.1002/jev2.12232. [PMID] 35656858.
2022
A Review of the Clinical Implications of Cachexia, Sarcopenia, and BMI in Patients with Peritoneal Carcinomatosis Receiving Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Cancers. 14(12) [DOI] 10.3390/cancers14122853. [PMID] 35740519.
2022
Eligibility Criteria Perpetuate Disparities in Enrollment and Participation of Black Patients in Pancreatic Cancer Clinical Trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 40(20):2193-2202 [DOI] 10.1200/JCO.21.02492. [PMID] 35316089.
2022
LGBTQ+ Inclusivity in Surgery-A Call to Action.
JAMA surgery. 157(4):288-290 [DOI] 10.1001/jamasurg.2021.6777. [PMID] 34985501.
2022
Racial Disparities in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Aggressive Surgical Treatment Overcome Cancer Health Inequities?
Frontiers in oncology. 12 [DOI] 10.3389/fonc.2022.899488. [PMID] 35756651.
2022
Review of Mechanisms and Treatment of Cancer-Induced Cardiac Cachexia.
Cells. 11(6) [DOI] 10.3390/cells11061040. [PMID] 35326491.
2022
Single-cell profiling of microenvironment components by spatial localization in pancreatic ductal adenocarcinoma.
Theranostics. 12(11):4980-4992 [DOI] 10.7150/thno.73222. [PMID] 35836806.
2022
The interleukin-1 axis and the tumor immune microenvironment in pancreatic ductal adenocarcinoma.
Neoplasia (New York, N.Y.). 28 [DOI] 10.1016/j.neo.2022.100789. [PMID] 35395492.
2022
The oral microbiome, pancreatic cancer and human diversity in the age of precision medicine.
Microbiome. 10(1) [DOI] 10.1186/s40168-022-01262-7. [PMID] 35701831.
2021
Diversification of Academic Surgery, Its Leadership, and the Importance of Intersectionality.
JAMA surgery. 156(8):748-756 [DOI] 10.1001/jamasurg.2021.1546. [PMID] 33950242.
2021
Diversity and Inclusion in Pancreatic Cancer Clinical Trials.
Gastroenterology. 161(6):1741-1746.e3 [DOI] 10.1053/j.gastro.2021.06.079. [PMID] 34416276.
2021
Five-Year Breast Surgeon Experience in LYMPHA at Time of ALND for Treatment of Clinical T1-4N1-3M0 Breast Cancer.
Annals of surgical oncology. 28(10):5775-5787 [DOI] 10.1245/s10434-021-10551-8. [PMID] 34365563.
2020
Disparities in Pancreatic Ductal Adenocarcinoma-The Significance of Hispanic Ethnicity, Subgroup Analysis, and Treatment Facility on Clinical Outcomes.
Cancer medicine. 9(12):4069-4082 [DOI] 10.1002/cam4.3042. [PMID] 32285629.
2019
The Microbiota and Cancer Cachexia.
International journal of molecular sciences. 20(24) [DOI] 10.3390/ijms20246267. [PMID] 31842339.

Grants

Dec 2020 – May 2022
The role of the IL-1/IL-1R/IL-1RA axis in the pancreatic ductal adenocarcinoma (PDAC) immune tumor microenvironment
Role: Principal Investigator
Funding: FREDERICK A COLLER SURGICAL SOCIETY

Contact Details

Phones:
Business:
(352) 328-2284
Addresses:
Business Mailing:
PO Box 100287
GAINESVILLE FL 32610